Piper Jaffray reduced its rating on Synageva (NASDAQ: GEVA ) from Overweight to Neutral and lowered its price target from $66 to $57. Piper Jaffray noted, "We are downgrading GEVA shares to Neutral from Overweight and reducing our price target to $57 from $66 as we see absence of